PremiumCompany AnnouncementsBurning Rock Biotech’s Strategic Growth and Financial Results Burning Rock Biotech Schedules AGM for December 2024 Burning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx PremiumCompany AnnouncementsBurning Rock Biotech Q2 Earnings and Strategic Shift Burning Rock Biotech to Delist from LSE Burning Rock Biotech Regains NASDAQ Compliance PremiumCompany AnnouncementsBurning Rock Biotech Executes Reverse ADS Split Burning Rock Biotech Announces Reverse ADS Split Burning Rock Biotech Files 2023 Annual Report